Formosa Optical Technology Co.,Ltd. (TPEX:5312)
Taiwan · Delayed Price · Currency is TWD 97.10
-1.10 (-1.12%)
Dec 5, 2025, 1:30 PM CST
TPEX:5312 Market Cap
TPEX:5312 has a market cap or net worth of 5.83 billion as of December 5, 2025. Its market cap has decreased by -7.52% in one year.
Market Cap
5.83B
Enterprise Value
6.26B
Revenue
3.98B
Ranking
n/a
PE Ratio
14.01
Stock Price
97.10
Market Cap Chart
Since April 28, 2006, TPEX:5312's market cap has increased from 1.52B to 5.83B, an increase of 284.88%. That is a compound annual growth rate of 7.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.83B | -10.92% |
| Dec 31, 2024 | 6.55B | 30.23% |
| Dec 29, 2023 | 5.03B | 44.31% |
| Dec 30, 2022 | 3.48B | -2.68% |
| Dec 30, 2021 | 3.58B | 0.34% |
| Dec 31, 2020 | 3.57B | -12.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 259.78B |
| PharmaEssentia | 189.73B |
| Heron Neutron Medical | 95.61B |
| Lotus Pharmaceutical | 78.24B |
| Bora Pharmaceuticals Co., LTD. | 65.19B |
| Lin BioScience | 34.45B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 32.34B |